Management of Hepatotoxicity in Tuberculosis Treatment

Immediate Management and Drug Reintroduction

When drug-induced liver injury occurs during TB treatment, immediately stop all hepatotoxic drugs and initiate a non-hepatotoxic regimen of streptomycin and ethambutol until liver function normalizes, then sequentially reintroduce drugs starting with isoniazid, followed by rifampin, and lastly pyrazinamide if needed, as recommended by the American College of Chest Physicians 1, 2
Stop all hepatotoxic TB drugs immediately when ALT levels are ≥3 times the upper limit of normal with hepatitis symptoms, or ≥5 times the upper limit of normal without symptoms, according to the Infectious Diseases Society of America 3
Exclude other causes of liver injury before attributing hepatotoxicity to anti-TB drugs, including viral hepatitis, biliary tract disease, alcohol, acetaminophen, lipid-lowering agents, and herbal supplements, as suggested by the Centers for Disease Control and Prevention 3, 4
Initiate a non-hepatotoxic holding regimen consisting of streptomycin and ethambutol to maintain some anti-TB activity while liver function recovers, as recommended by the American Thoracic Society 1, 2

Check liver function tests weekly for the first 2 weeks after each drug reintroduction, and continue monitoring every 2 weeks for the first 2 months, as recommended by the American College of Chest Physicians 1, 2
Educate patients about hepatotoxicity symptoms and instruct them to stop medications immediately and seek medical attention if these occur, according to the Centers for Disease Control and Prevention 1, 2

If pyrazinamide cannot be tolerated, use isoniazid, rifampin, and ethambutol for 2 months, followed by isoniazid and rifampin for 7 months, as recommended by the American Thoracic Society 5, 1, 2
If isoniazid cannot be tolerated, use rifampin, ethambutol, and a fluoroquinolone for 12 months, as suggested by the Infectious Diseases Society of America 1, 2

Patients with pre-existing liver disease, chronic alcohol use, hepatitis B/C infection, HIV infection, malnutrition, or advanced age are at higher risk for both initial hepatotoxicity and recurrence, requiring more intensive monitoring, according to the Centers for Disease Control and Prevention 6, 7, 4
Avoid concurrent hepatotoxic medications during TB treatment and reintroduction, as recommended by the American College of Chest Physicians 3, 4
For TB meningitis or pericarditis, treatment duration may need extension to 9-12 months even with standard regimens, and corticosteroids should be added to prevent complications, as suggested by the American Thoracic Society 1